Have your own idea? Try our Stock Screener
Over the last 7 days, the Life Sciences industry has dropped 3.7%, driven by a pullback from Danaher of 3.6%. On the other hand Azenta is actually up 7.7%. The industry has fallen 6.6% in the last year. Earnings are forecast to grow by 18% annually.
Has the U.S. Life Sciences Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Sat, 21 Dec 2024 | US$644.4b | US$142.4b | US$10.2b | 43.6x | 63x | 4.5x |
Mon, 18 Nov 2024 | US$638.7b | US$142.4b | US$10.4b | 41.8x | 61.6x | 4.5x |
Wed, 16 Oct 2024 | US$736.4b | US$141.8b | US$8.5b | 37.3x | 86.7x | 5.2x |
Fri, 13 Sep 2024 | US$738.4b | US$141.8b | US$8.5b | 37.7x | 86.9x | 5.2x |
Sun, 11 Aug 2024 | US$727.5b | US$141.5b | US$8.5b | 38.2x | 85.8x | 5.1x |
Tue, 09 Jul 2024 | US$664.6b | US$141.3b | US$12.2b | 38.8x | 54.6x | 4.7x |
Thu, 06 Jun 2024 | US$705.0b | US$141.3b | US$12.4b | 39.9x | 56.7x | 5x |
Sat, 04 May 2024 | US$708.1b | US$141.7b | US$12.5b | 38.9x | 56.6x | 5x |
Mon, 01 Apr 2024 | US$744.3b | US$142.0b | US$12.8b | 44x | 58.2x | 5.2x |
Wed, 28 Feb 2024 | US$728.5b | US$142.2b | US$12.8b | 44.1x | 57.1x | 5.1x |
Fri, 26 Jan 2024 | US$686.7b | US$153.8b | US$14.2b | 35.1x | 48.5x | 4.5x |
Sun, 24 Dec 2023 | US$698.9b | US$153.8b | US$14.2b | 37.5x | 49.1x | 4.5x |
Tue, 21 Nov 2023 | US$610.6b | US$153.9b | US$13.9b | 33.5x | 43.9x | 4x |
Thu, 19 Oct 2023 | US$612.3b | US$154.6b | US$11.2b | 31.8x | 54.7x | 4x |
Sat, 16 Sep 2023 | US$692.7b | US$154.6b | US$11.2b | 33.3x | 61.8x | 4.5x |
Mon, 14 Aug 2023 | US$725.3b | US$154.7b | US$11.5b | 32x | 63.1x | 4.7x |
Wed, 12 Jul 2023 | US$695.5b | US$152.4b | US$12.5b | 29.7x | 55.6x | 4.6x |
Fri, 09 Jun 2023 | US$680.8b | US$152.4b | US$12.5b | 29.1x | 54.5x | 4.5x |
Sun, 07 May 2023 | US$703.0b | US$152.4b | US$12.9b | 30.5x | 54.6x | 4.6x |
Tue, 04 Apr 2023 | US$722.6b | US$154.6b | US$10.8b | 26.8x | 66.9x | 4.7x |
Thu, 02 Mar 2023 | US$707.6b | US$154.4b | US$10.9b | 29.8x | 64.9x | 4.6x |
Sat, 28 Jan 2023 | US$761.6b | US$155.5b | US$9.0b | 31.1x | 84.7x | 4.9x |
Mon, 26 Dec 2022 | US$743.5b | US$155.2b | US$8.8b | 28.8x | 84.7x | 4.8x |
Wed, 23 Nov 2022 | US$760.2b | US$155.1b | US$8.8b | 28.5x | 86.7x | 4.9x |
Fri, 21 Oct 2022 | US$680.5b | US$152.5b | US$17.0b | 24.3x | 40x | 4.5x |
Sun, 18 Sep 2022 | US$752.0b | US$152.3b | US$17.3b | 28.6x | 43.4x | 4.9x |
Tue, 16 Aug 2022 | US$846.3b | US$152.1b | US$17.3b | 32.7x | 49x | 5.6x |
Thu, 14 Jul 2022 | US$739.2b | US$148.1b | US$20.1b | 30.2x | 36.8x | 5x |
Sat, 11 Jun 2022 | US$712.0b | US$148.1b | US$20.1b | 29x | 35.4x | 4.8x |
Mon, 09 May 2022 | US$736.4b | US$147.7b | US$20.0b | 31.2x | 36.8x | 5x |
Wed, 06 Apr 2022 | US$871.5b | US$146.5b | US$25.3b | 36.2x | 34.4x | 5.9x |
Fri, 04 Mar 2022 | US$849.1b | US$146.2b | US$25.3b | 37.8x | 33.6x | 5.8x |
Sun, 30 Jan 2022 | US$829.5b | US$139.4b | US$27.9b | 38.8x | 29.8x | 6x |
Tue, 28 Dec 2021 | US$994.9b | US$138.0b | US$27.3b | 45.6x | 36.4x | 7.2x |
36.4x
Which industries have driven the changes within the U.S. Healthcare industry?
US Market | -3.53% | |
Healthcare | -3.69% | |
Life Sciences | -3.74% | |
Clinical Research and Equipment | -3.74% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
AZTA Azenta | US$50.43 | 12.2% +US$250.7m | -21.8% | PS3.5x | |
PSNL Personalis | US$5.75 | 50.5% +US$136.4m | 292.5% | PS4.6x | |
WST West Pharmaceutical Services | US$331.40 | 0.4% +US$97.8m | -6.6% | PE48x | |
LAB Standard BioTools | US$2.00 | 4.7% +US$33.5m | 0.5% | PS4.8x | |
BLFS BioLife Solutions | US$27.39 | 2.6% +US$32.0m | 70.9% | PS8.6x |